New nivolumab combination therapies for AML
There has historically been less novel agents being tested and moving into the clinic for AML. Now, there has been a wave of promising trials. Speaking from the American Society of Hematology (ASH) 20...
Author: VJHemOnc
Added: 12/13/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Hematology